Microbiologist Mario Feldman warns "we are losing the battle against bacteria"
Mario Feldman, the first graduate in Biotechnology from the National University of Rosario and now a professor of Molecular Microbiology at Washington University in St. Louis, warns about bacterial resistance to antibiotics, a "silent pandemic." His laboratory studies Acinetobacter baumannii and strategies that target virulence factors instead of killing the microorganism. He also co-founded Omniose, which develops bacterial vaccines with a biological platform and collaborates with AstraZeneca, and received about 15 million dollars in research grants.
In 35 seconds
- Feldman leads research on antibiotic-resistant bacteria at Washington University's School of Medicine in St. Louis.
- His laboratory works with Acinetobacter baumannii, linked to severe hospital-acquired infections.
- He studies targeting bacterial virulence factors instead of directly eliminating the microorganism.
Read the full story at La Nación
IASummary generated by artificial intelligence from a story by La Nación. It may contain errors: the original source prevails.
Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.